Progyny, Inc. financial data

Symbol
PGNY on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
1359 Broadway, 2 Nd Floor, New York, NY
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Auxogyn, Inc. (to 3/19/2015), Auxogyn Inc (to 9/16/2013)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 310 % +15.7%
Debt-to-equity 42 % -11.5%
Return On Equity 12 % -1.81%
Return On Assets 8.43 % +2.06%
Operating Margin 5.71 % +92.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.3M shares -5.38%
Common Stock, Shares, Outstanding 90.7M shares -4.68%
Entity Public Float 3.3B USD +43.5%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 93.9M shares -0.92%
Weighted Average Number of Shares Outstanding, Diluted 97.8M shares -2.76%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.09B USD +38.3%
Selling and Marketing Expense 61.7M USD +14.7%
General and Administrative Expense 117M USD +5.49%
Operating Income (Loss) 71.2M USD +59.1%
Nonoperating Income (Expense) 13.6M USD +207%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 84.8M USD +72.4%
Income Tax Expense (Benefit) 22M USD +294%
Net Income (Loss) Attributable to Parent 62.8M USD +27.3%
Earnings Per Share, Basic 0.67 USD/shares +26.4%
Earnings Per Share, Diluted 0.63 USD/shares +28.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95M USD -44.3%
Accounts Receivable, after Allowance for Credit Loss, Current 294M USD +10.9%
Assets, Current 582M USD +3.76%
Deferred Income Tax Assets, Net 67.9M USD -11.9%
Property, Plant and Equipment, Net 10.6M USD +12%
Operating Lease, Right-of-Use Asset 17.8M USD -3.5%
Goodwill 15.6M USD +31.4%
Other Assets, Noncurrent 2.98M USD -15.2%
Assets 699M USD +2.51%
Accounts Payable, Current 152M USD +16.6%
Employee-related Liabilities, Current 11.9M USD +54%
Liabilities, Current 225M USD +16.2%
Operating Lease, Liability, Noncurrent 17.1M USD -5.92%
Liabilities 242M USD +14.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.03M USD +87.2%
Retained Earnings (Accumulated Deficit) 123M USD +104%
Stockholders' Equity Attributable to Parent 456M USD -2.83%
Liabilities and Equity 699M USD +2.51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 25.7M USD +22.8%
Net Cash Provided by (Used in) Financing Activities -27.4M USD -1385%
Net Cash Provided by (Used in) Investing Activities 19.3M USD +19.9%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 97M shares +1.96%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17.7M USD -49.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 95M USD -44.3%
Deferred Tax Assets, Valuation Allowance 513K USD +129%
Deferred Tax Assets, Gross 80.3M USD -1%
Operating Lease, Liability 19.9M USD +1.41%
Payments to Acquire Property, Plant, and Equipment 850K USD -32.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 63.7M USD +26.5%
Lessee, Operating Lease, Liability, to be Paid 24.4M USD -1.98%
Property, Plant and Equipment, Gross 15.5M USD +35%
Operating Lease, Liability, Current 2.8M USD +93.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.99M USD +7.13%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.99M USD +33%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.55M USD -14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.99M USD +7.13%
Deferred Tax Assets, Operating Loss Carryforwards 16.8M USD -59.1%
Unrecognized Tax Benefits 390K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.99M USD +7.13%
Operating Lease, Payments 300K USD 0%
Depreciation, Depletion and Amortization 716K USD +32.3%
Deferred Tax Assets, Net of Valuation Allowance 79.8M USD -1.36%
Share-based Payment Arrangement, Expense 124M USD +7.8%